New York City, NY -- (SBWIRE) -- 10/30/2013 -- StockMarketIntel.com issues a special report on the following stocks: Biozone Pharmaceuticals Inc (OTCBB:BZNE), Fairfax Financial Holdings Ltd (OTCMKTS:FRFHF), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Towers Watson & Co (NYSE:TW)
Biozone Pharmaceuticals Inc (OTCBB:BZNE) declined -3.03%, trading on 618,608 shares, to end the trade at $0.800. The stock changed hands in a range of $0.74 to $0.85, bringing its market capitalization to about $55.69 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.16 and was moved to the maximum level of $3.75. Biozone Pharmaceuticals, Inc. (Biozone Pharma), formerly International Surf Resorts, Inc., through its wholly owned subsidiary, BioZone Laboratories, Inc., which primarily is engaged in the business of developing and manufacturing over the counter (OTC) drug products and cosmetic and beauty products on behalf of third parties. In addition, through Biozone Pharma’s wholly owned subsidiaries, Equalan LLC and Baker Cummins Corp., the Company markets two lines of skin care products.
Has BZNE Found The Bottom And Ready To Gain Momentum? Find Out Here
Fairfax Financial Holdings Ltd (OTCMKTS:FRFHF) declined -1.55%, to complete the trading session at $446.00 with a total volume of 1,792 shares. The stock, on average, trades on a volume of 7,004 shares. It floated in a range of $446.00 to $454.09 during the last trading session, with a beta value of 0.72. Its market capitalization now moved to about $15.76 billion. In the past 52 weeks, the share price has not declined below $366.66 and above $456.00. Fairfax Financial Holdings Limited (Fairfax) is a financial services holding company. The Company, through its subsidiaries, is principally engaged in property and casualty insurance and reinsurance and the associated investment management.
Why Should Investors Buy FRFHF After the Recent Fall? Just Go Here and Find Out
Celldex Therapeutics, Inc. (NASDAQ:CLDX) recorded a gain of 3.57% and was in a range of $23.37-$24.69 before closing at $24.39. The share price hit its 52-week low of $5.02 and $38.84 was the best price. The stock completed the day with a total volume of 2.65 million shares, versus an average volume of 3.83 million shares. Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company's drug candidates include CDX-110, CDX-011 and CDX-1127. CDX-110, is an immunotherapeutic vaccine that targets the tumor-specific molecule, epidermal growth factor receptor variant III (EGFRvIII).
What was the Moving Force behind CLDX on Bullish Run? Read This Research Report
Towers Watson & Co (NYSE:TW) added 0.87% yesterday, bringing its market capitalization around $8.76 billion. The total number of shares that changed hands during the session was 546,113shares, as compared to average trading volume of 918,577 shares. The share price, after opening at $114.58, made a high of $115.81 and hovered above $113.47 to end the day at $115.16. Towers Watson & Co. (Towers Watson) is a global professional services company. The Company offers solutions in the areas of benefits, talent management, rewards, and risks and capital management. The Company offers its clients comprehensive services across four business segments: Benefits, Risk and Financial Services, Talent and Rewards, and exchanges Solutions.
For How Long TW will fight for Profitability? Read This Trend Analysis report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)